15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer - Wikidata - wikimedia - TriplyDB

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

http://www.wikidata.org/entity/Q28592082

about

Regulation of inflammation in cancer by eicosanoids Molecular origins of cancer: Molecular basis of colorectal cancer Regulation of immune responses by prostaglandin E2 Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂ Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer Prostaglandins and cancer Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2 Stimulation of suicidal erythrocyte death by lipoxygenase inhibitor Bay-Y5884 Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems.11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid.Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.Analysis of endogenous glutathione-adducts and their metabolites.Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis Stable-isotope dilution LC–MS for quantitative biomarker analysis.miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo.Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma.A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell.Targeting the eicosanoid pathway in non-small-cell lung cancer.Eicosanoids and cancer Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis Crucial role of macrophage selenoproteins in experimental colitis.The tumor microenvironment in colorectal carcinogenesis.15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.

P2860

09da4d67f6219e5922a69bdd5c96db92e6b6383a 95c6a40a12f0982fee91ae52abce62964b6326f7

P248

Q24564308-FDE4C753-4549-4823-8CAB-0A476EE2B654 Q24617331-9DE51E67-93B5-4260-9148-018886C8D680 Q26849305-46F90E5B-930D-4093-BB09-3B2D3A8DAA0F Q27008521-733242CB-1285-4601-B2A5-E7D3E61DB980 Q28067664-BB37C485-D9C1-404B-8DB8-E051EFC1A271 Q28083349-20038DEF-4041-408C-AA16-81744DAD79C0 Q28084346-4A9E7D13-6374-4465-BF0F-30BE20D021B7 Q28188827-3253EDD5-0C25-467E-BC69-14C806B47E1A Q28209990-B05176C9-5258-4A9B-A690-D051DF4CC45A Q28212522-3AA5A383-AF09-47D1-A172-AAD368D71BBA Q28218639-1D0A7A83-515E-4274-ABA8-02C1B2492CBF Q28274081-4A81CD35-D8F3-45C5-96C3-1A6830460DE9 Q28281228-3CBEA7E5-7891-428E-9D4B-7268AB40E508 Q30486725-064D4645-2C13-439F-825D-38E94D1416BC Q33313240-C1B3C727-D86A-4ACB-A6C7-983610DA4E22 Q33443229-D6C18D23-A0D2-4B73-B7DD-3A10FBF1429F Q33451846-2221371B-6C98-4CF5-935D-FC95371694DC Q33458922-A26137D1-C527-4439-91F5-CAB1F6B01797 Q33519106-90B98904-4A16-4860-B0C2-D9A26B9FDBB3 Q33526510-59C5892C-3035-4D78-8DC1-92976C0C2362 Q33648694-6FD9A551-A16A-4B3D-9729-3BE660BE65A7 Q33705258-AAB8FB3D-A955-4B7B-AFFF-F93A8AA376AC Q33747062-D3E38E48-2BD9-4F98-B94B-282623B2F6DB Q33758343-D70ABB74-03BF-413D-8553-D319F1305FF0 Q33759512-196AA866-BE94-4010-96A1-E1AC5A33082A Q33770260-FC9D7BBD-C5BA-43A9-A777-61ACD3B278A4 Q33773701-F560AAC1-471B-49BE-BE97-40999C77E7E4 Q33798719-56040E53-B5E9-469B-9AD5-27665104D01F Q33864360-94B04001-7203-4DB8-9B27-10B75046161F Q33872540-6B4A140E-B929-456A-B2CE-611863E0666E Q33882846-7E8971B8-6C4F-4B6D-AECF-89E219CFB784 Q33936807-931DB999-565B-48D6-9F2F-38A13AEB4C32 Q33966203-BC37A6A7-F073-40C7-BD5D-7A89D5C94F04 Q34015084-5E06DCDD-2A8C-40D5-B5B1-FC6DF2E29398 Q34017114-1DDBC942-6B22-4C51-9BAD-E4DACB1C900E Q34141517-634AC059-BDD3-41FC-8746-B167EF65CD8B Q34218777-466679CC-2253-42D0-8D16-FFB924BEF244 Q34343645-C2E63EBE-216F-4CF0-B1A7-54A0D2FFDF2A Q34987471-45051E01-3DCB-497B-B0E6-56EBDC2BA666 Q35033202-0BA7CF49-645E-454F-903D-4FEDF1AE3056

P2860

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

http://www.wikidata.org/entity/Q28592082

description

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2005

@ast

im Februar 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2005/02/04)

@sk

vědecký článek publikovaný v roce 2005

@cs

wetenschappelijk artikel (gepubliceerd op 2005/02/04)

@nl

наукова стаття, опублікована в лютому 2005

@uk

name

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@ast

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@en

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@nl

type

label

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@ast

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@en

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@nl

prefLabel

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@ast

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@en

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@nl

P1433

Q28592082-4AD09AC3-6EB8-456E-AE9C-10AE25135C34

P1476

Q28592082-18F48C60-C55D-4842-B913-E9CFB63BED2E

P2093

Q28592082-016511D2-FF13-40E5-A1D4-5A4FC3B52F5A

Q28592082-0394A66C-CDE3-48FB-B416-25FD077C6B97

Q28592082-16D2F57E-86AE-4D72-811E-2148F5AB8CAE

Q28592082-32978031-D4AD-4E31-BAD5-4B9A35B2AB75

Q28592082-9A32864A-F3A4-47B8-A3F4-F15C28E88E5D

Q28592082-A6890317-3B17-4603-9DD2-CB146CC778F2

Q28592082-BD935D24-52A6-45B9-BC9C-28EE5A23B586

P2860

Q28592082-2054B1EF-2E0B-4CED-BEBF-F00A5FF99EA4

Q28592082-20A719CB-3404-452E-91D2-486079BD06CE

Q28592082-22D626D8-D6C6-46E7-A38F-171BFAFDC8DF

Q28592082-23389A70-E4DF-4034-BAC3-4D110ADA46B2

Q28592082-2D134EE5-9E0A-4012-B76F-21506C4AC0F5

Q28592082-387F882B-3D5D-465F-9047-073433281D3C

Q28592082-3A651B0D-A911-4B88-B26E-91DD42254191

Q28592082-3D87AA6B-611F-4435-AFDA-B334FE9F7611

Q28592082-4268A57E-0FD7-4813-8C46-B13973968A9C

Q28592082-43FD57BC-24A3-458C-B676-DFF79FF328ED

P304

Q28592082-45561E65-EB87-40E3-B0F1-3E47D0A72054

P31

Q28592082-2BD368DB-BBCB-4FD5-8ABF-4D9B2F7C78E4

P3181

Q28592082-066A0C30-0C19-4896-8435-6892127DD178

P356

Q28592082-65A4A8FA-C8AE-4A06-9868-A1C9C97B16EA

P407

Q28592082-E2660ADC-84F4-467E-A785-195B25657B94

P433

Q28592082-89A7515F-591A-4AF8-A22F-4459BCF011F3

P478

Q28592082-24F20A05-8C90-46C2-86C0-A0562C97B454

P50

Q28592082-C8F8EA33-7B9C-4D95-AEE0-05DE4857B1C1

Q28592082-E40C3162-D39B-45A8-B9CF-29092989B722

P577

Q28592082-FD051F7E-E897-430F-8D47-6103D5CD507E

P698

Q28592082-4A22E1FC-59B0-4444-9F79-94581E99137E

P921

Q28592082-6D819CDA-1BAA-44E3-8048-9118E95BB2AF

Q28592082-BD397417-972C-46C2-8BA9-019A2395B149

P932

Q28592082-6D99588A-84AF-49E9-80A1-9B9CF6E63EB0

P3181

P356

P1433

Journal of Biological Chemistry

P1476

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

@en

P2093

F Gregory Buchanan

http://www.w3.org/2001/XMLSchema#string

Hsin-Hsiung Tai

http://www.w3.org/2001/XMLSchema#string

Jason R Mann

http://www.w3.org/2001/XMLSchema#string

Michael G Backlund

http://www.w3.org/2001/XMLSchema#string

Raymond N DuBois

http://www.w3.org/2001/XMLSchema#string

Sharada Katkuri

http://www.w3.org/2001/XMLSchema#string

Vijaykumar R Holla

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene

Altered eicosanoid levels in human colon cancer

Epidermal growth factor-related peptides and their receptors in human malignancies

Chromosomal localization of the type-I 15-PGDH gene to 4q34-q35

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Indomethacin increases 15-PGDH mRNA expression in HL60 cells differentiated by PMA.

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

P304

3217-3223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2035971

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M411221200

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P50

Ginger Lohr Milne

P577

2004-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15542609

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Hydroxyprostaglandin dehydrogenase 15 (NAD)

P932

1847633

http://www.w3.org/2001/XMLSchema#string